(Q33856972)

English

Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

17

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

8

object named as

Tapan Kadia

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

object named as

Elias Jabbour

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

10

object named as

Sherry Pierce

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Guillermo Garcia-Manero

3

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

7

object named as

Sergio Giralt

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

12

object named as

Naval Daver

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Richard E Champlin

4

object named as

Richard Champlin

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Michael S Mathisen

2

object named as

Michael S Mathisen

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

16

object named as

Simrit Parmar

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

15

object named as

Betul Oran

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

object named as

Uday Popat

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

object named as

Julianne Chen

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

object named as

Ebru Koca

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lilian Maria Sobreira Tanaka

13

object named as

Maria Tanaka

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Gabriela Rondon

14

object named as

Gabriela Rondon

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

object named as

Issa Khouri

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Marcos de Lima

18

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

24 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

American Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

88

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

198-200

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085133

5 July 2018

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23371

21 January 2018

5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23371

21 January 2018

Identifiers

10.1002/AJH.23371

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

release_vcqb4a3ibvcgblmrf5furpjaf4

1 reference

https://api.fatcat.wiki/v0/release/vcqb4a3ibvcgblmrf5furpjaf4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33856972&oldid=1835516927"